Kidney Diseases: Clinical Trials

13,341 trials for Kidney Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6974 completed, 1899 unknown, 1578 recruiting, 1019 terminated. 3602 Not applicable, 2487 Phase 2, 1791 Phase 1, 1273 Phase 3, 1085 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3602Completed 1818, Unknown 575, Recruiting 458, Not yet recruiting 256, Terminated 215, Active not recruiting 124, Withdrawn 118, Enrolling by invitation 30, Suspended 8
Phase 22487Completed 1266, Terminated 339, Recruiting 296, Unknown 247, Active not recruiting 125, Withdrawn 110, Not yet recruiting 85, Enrolling by invitation 10, Suspended 9
Phase 11791Completed 1059, Recruiting 210, Terminated 198, Unknown 111, Active not recruiting 98, Withdrawn 52, Not yet recruiting 51, Suspended 8, Enrolling by invitation 4
Phase 31273Completed 718, Terminated 148, Unknown 134, Recruiting 116, Active not recruiting 65, Withdrawn 54, Not yet recruiting 30, Enrolling by invitation 5, Suspended 3
Phase 41085Completed 578, Unknown 207, Terminated 97, Recruiting 82, Withdrawn 47, Not yet recruiting 40, Active not recruiting 25, Suspended 5, Enrolling by invitation 4
Early Phase 1135Completed 58, Recruiting 26, Not yet recruiting 17, Unknown 12, Active not recruiting 7, Terminated 5, Withdrawn 5, Enrolling by invitation 4, Suspended 1

Follow Kidney Diseases: new trials by email Literature Review of Kidney Diseases trials Research Report on Kidney Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30
serum creatinine assay - Acute Kidney Injury (Nontraumatic), Contrast-induced Nephropathy
WithdrawnMaastricht University Medical Center2097-11-012023-10-19
Time to Excretion of Contrast, a Maastricht Prospective Observational Study
Contrast concentration in urine - Renal Insufficiency, Acute Kidney Injury
WithdrawnMaastricht University Medical Center2097-11-012023-10-19
Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast
serum creatinine assay - Renal Insufficiency, Acute Kidney Injury
WithdrawnMaastricht University Medical Center2097-05-012023-10-19
MRI Technical Development and Applications in Kidney Disease
Chronic Kidney Diseases, Kidney Transplantation
Not yet recruitingUniversity of Minnesota1802028-06-302026-04-13
Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)
NM8074 - IgA Nephropathy
Phase 2Not yet recruitingNovelMed Therapeutics102028-02-012026-04-13
Precision-Medicine Diagnostic Support in Hospitalized Veterans With Acute Kidney Injury
PRECISE-AKI Clinical Decision Support Tool - Acute Kidney Injury (AKI)
Not applicableNot yet recruitingVA Office of Research and Development602028-01-012026-11-02
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP)
CB-010 - Systemic Lupus Erythematosus, Lupus
Phase 1WithdrawnCaribou Biosciences, Inc.2027-12-012025-09-19
Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy
NM8074 - aHUS - Atypical Hemolytic Uremic Syndrome
Phase 2Not yet recruitingNovelMed Therapeutics122027-11-012026-04-13
Veteran Centered Meal Intervention in Chronic Kidney Disease
Medically tailored meals (MTMs) - Chronic Kidney Disease
Not applicableNot yet recruitingVA Office of Research and Development1002027-10-012026-09-03
Amino Acid Therapy Evaluating the Incidence of New-Onset AKI
Amino Acid infusion, Lactated Ringer Solution - Acute Kidney Injury
Phase 2Not yet recruitingChildren's Hospital Medical Center, Cincinnati2702027-10-012026-10-21
Technology-enabled Social Network Intervention to Increase Live Donor Kidney Transplantation
Digital education outreach intervention for kidney transplant access and human guide, Digital education outreach intervention for kidney transplant access only (unguided) - End-Stage Renal Disease, Chronic Kidney Diseases
Not applicableNot yet recruitingState University of New York at Buffalo5502027-10-012026-10-20
DESIR. Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal Failure
blood sampling, Blood sampling - Renal Impairment, Digestive Cancers
Not yet recruitingCentre Hospitalier Universitaire de Besancon7422027-10-012026-11-02
The Reducing Adverse Outcomes in Dialysis by Adjusting the pRescription for Dialysate Potassium Trial
PKRxHD, Dialysis - End Stage Kidney Disease
Not applicableNot yet recruitingNYU Langone Health1202027-10-012026-11-17
Anti-Interleukin-6 (IL6) in Calciphylaxis
Tocilizumab - Calciphylaxis
Phase 1Not yet recruitingBoston Medical Center102027-09-012026-07-16
A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases
CD19-targeted iNKT Cell Injection - IgA Nephropathy (IgAN), Membranous Nephropathy
Early Phase 1Not yet recruitingGrit Biotechnology302027-08-012026-09-11
Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health
INTEGRATE-CHW, Usual Care - Hypertension (HTN), CKD - Chronic Kidney Disease
Not applicableNot yet recruitingFlorida International University2002027-07-152026-11-05
Trial Without Borders IMPLEMENT-CKD: IMPLEMENTation of Evidence-Based SGLT2i to Reduce Global Burden of Cardiovascular and Chronic Kidney Disease
Implementation of recommendations - Implementation Research, Kidney Disease
Not yet recruitingThe University of Queensland13902027-07-012026-10-02
Heterozygous Individuals for AGXT and Kidney Stones
Controlled Diet - Kidney Stone, Urolithiasis, Calcium Oxalate
Not applicableEnrolling by invitationUniversity of Alabama at Birmingham42027-07-012026-08-31
Sarcopenia in Chronic Kidney Disease (CKD) Patients
Valine, EEA - Chronic Kidney Disease, Sarcopenia
Early Phase 1Not yet recruitingThe University of Texas Health Science Center at San Antonio202027-07-012026-11-02
Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial
Balstilimab, Biospecimen Collection, Botensilimab - Clear Cell Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v8
Phase 2RecruitingNational Cancer Institute (NCI)162027-05-172026-10-21

Showing 20 of 13341. Sign in to see all of them.

Narrower conditions

Renal Insufficiency, Chronic (3097)  ·  Kidney Failure, Chronic (2009)  ·  Carcinoma, Renal Cell (1968)  ·  Acute Kidney Injury (1623)  ·  Renal Insufficiency (1380)  ·  Kidney Neoplasms (958)  ·  Diabetic Nephropathies (518)  ·  Kidney Calculi (507)  ·  Diabetes Mellitus (402)  ·  Diabetes Mellitus, Type 2 (368)  ·  Melanoma (366)  ·  Hypertension (360)  ·  Neoplasms (349)  ·  Lupus Nephritis (337)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (13340)  ·  Female Urogenital Diseases (13339)  ·  Male Urogenital Diseases (13339)  ·  Urogenital Diseases (13321)  ·  Urologic Diseases (13273)  ·  Pathological Conditions, Signs and Symptoms (6859)  ·  Renal Insufficiency (5983)  ·  Pathologic Processes (5981)  ·  Disease Attributes (5146)  ·  Chronic Disease (4880)  ·  Neoplasms by Site (2648)  ·  Urogenital Neoplasms (2591)  ·  Urologic Neoplasms (2574)  ·  Neoplasms (2479)

Interventions

Nivolumab (159)  ·  pembrolizumab (153)  ·  Sunitinib (151)  ·  Cyclophosphamide (142)  ·  Blood Specimen Collection (141)  ·  Mycophenolic Acid (135)  ·  Tacrolimus (124)  ·  Everolimus (107)  ·  dapagliflozin (96)  ·  Saline Solution (93)  ·  Sorafenib (93)  ·  Standard of Care (90)  ·  Prednisone (88)  ·  Bevacizumab (87)  ·  Sodium Chloride (87)

Sponsors

National Cancer Institute (NCI) (180)  ·  Assiut University (163)  ·  Novartis Pharmaceuticals (125)  ·  Pfizer (120)  ·  Bayer (108)  ·  AstraZeneca (107)  ·  Mayo Clinic (103)  ·  Assistance Publique - Hôpitaux de Paris (101)  ·  Amgen (92)  ·  National Taiwan University Hospital (75)  ·  Ain Shams University (70)  ·  Seoul National University Hospital (70)  ·  M.D. Anderson Cancer Center (68)  ·  Hospices Civils de Lyon (66)  ·  University of Colorado, Denver (65)

Countries

United States (4883)  ·  China (1268)  ·  France (1135)  ·  Germany (870)  ·  Canada (862)  ·  United Kingdom (799)  ·  Italy (749)  ·  Spain (666)  ·  South Korea (503)  ·  Australia (449)  ·  Netherlands (420)  ·  Belgium (411)  ·  Turkey (Türkiye) (404)  ·  Poland (381)  ·  Taiwan (381)

Top investigators

Alp Ikizler, MD (19)  ·  Giuseppe Remuzzi, MD (16)

Results publications

PMID 40576086, PMID 39356039, PMID 36005278, PMID 38299639, PMID 37146227, PMID 35224730, PMID 36791280, PMID 35018639, PMID 36416787, PMID 39513526, PMID 37916745, PMID 34778952, PMID 34519356, PMID 38770818, PMID 33107592, PMID 33314078, PMID 35224732, PMID 31401903, PMID 32390133, PMID 33586138, PMID 37870148, PMID 38189593, PMID 38682786, PMID 39963952, PMID 27238653, PMID 28410911, PMID 33783815, PMID 37651553, PMID 38018702, PMID 38724717, PMID 39878152, PMID 33283264, PMID 34164803, PMID 36472416, PMID 37528520, PMID 39607014, PMID 40337980, PMID 40465397, PMID 32588430, PMID 33782940, PMID 38864363, PMID 41385299, PMID 25577718, PMID 26032537, PMID 35230699, PMID 37250503, PMID 38837240, PMID 39151033, PMID 39171639, PMID 41805697

NIH funding

2023 (87), 2016 (60), 2018 (48), 2025 (45), 2017 (42), 2019 (41), 2014 (40), 2015 (39), 2008 (28), 2009 (25), U10CA180886 (22), P30CA033572 (21), P30CA043703 (14), U10CA098543 (14), 2005 (13)